Flyer

Archives in Cancer Research

  • ISSN: 2254-6081
  • Journal h-index: 11
  • Journal CiteScore: 0.91
  • Journal Impact Factor: 0.6
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
20+ Million Readerbase
Indexed In
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • OCLC- WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Google Scholar
  • Secret Search Engine Labs
Share This Page
Recommended Webinars & Conferences

13th World Congress on Breast Cancer Research & Therapies

Amsterdam, Netherlands

10th International Summit on Cancer Research and Diagnosis

Amsterdam, Netherlands

Stanbery Hannah

Department of Medicine, University of Toledo, USA

Publications
  • Mini Review   
    Personalized medicine and immunotherapy for ovarian cancer
    Author(s): Stanbery Hannah*

    The general prognosis for women with advanced ovarian cancer is still dismal, despite advancements in surgery and chemotherapy. Although platinum-based chemotherapy has an initial response rate of roughly 60–80%, the majority of patients will have a recurrence and pass away from the disease. However, a precision medicine approach focused on DNA repair has lately given rise to genuine optimism about increasing survival. Many individuals with BRCA germlinedeficient and/or platinum-sensitive epithelial ovarian malignancies have seen lifechanging effects as a result of the clinical development of PARP inhibitors. Patients' prognosis could also be improved by intraperitoneal chemotherapeutic methods and antiangiogenic medications. Additionally, developing immunotherapeutic possibilities could benefit patient results. The effectiveness of immunother.. Read More»

    DOI: 10.36648/2254-6081-11.2-153

    Abstract HTML PDF